News

TMCnet1d
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by CDP, the world's foremost ...
The Diplomat4d
As US Decouples, China Strengthens Biotech Ties With Japan
From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.
GEN - Genetic Engineering and Biotechnology News5d
WuXi Biologics Reports Completion of First Commercial PPQ Campaign at 15,000 L Production Line
Single-use technology manufacturing can attain cost-of-goods that are comparable to stainless-steel systems, noted WuXi.
Small Molecule Innovator API CDMO Market To Hit $47.14 Billion By 2030 At 6.38% CAGR, Driven By Outsourcing Trends And Drug Innovation
CDMOs Expand Capabilities Amid Surge in Clinical Trials and Demand for Orphan Drugs and Novel TherapiesDublin, April 18, 2025 (GLOBE NEWSWI ...
Salamanca Press5d
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site
The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,000L single-use bioreactors ...
Le Lézard5d
APSEZ acquires 50 MTPA capacity NQXT Australia, accelerating path to 1 billion tonnes p.a. by 2030
The Board of Directors of Adani Ports and Special Economic Zone Ltd. (APSEZ), India's largest integrated Transport Utility company has approved the acquisition of Abbot Point Port Holdings Pte Ltd ...
Le Lézard6d
Amogy Accelerates Commercialization of Ammonia Cracking Catalyst in Partnership with JGC
Amogy, a provider of mature, scalable, and efficient ammonia-to-power solutions, today announced the first pilot plant deployment of its advanced ammonia cracking catalyst with JGC Holdings ...